These findings indicate that the metabolism of short-chain fatty acids may influence the expression of NKG2D ligands through multiple mechanisms, thereby potentially enhancing NK cells’ ability to recognize and kill tumor cells. The gene discussed is KLRK1; the disease is neoplasm.